SURROZEN INC-CW25 (SRZNW:NASDAQ)
$0.0191 0 (0%)
Analysed SURROZEN INC-CW25 (SRZNW:NASDAQ) News Sources
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
15-04-2026
yahoo.com
Surrozen (SRZN) Surges 5.9%: Is This an Indication of Further Gains?
14-04-2026
yahoo.com
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
23-03-2026
yahoo.com
Surrozen to Present at Upcoming Healthcare Investor Conference
25-02-2026
yahoo.com
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23-02-2026
yahoo.com
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
07-11-2025
yahoo.com
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04-09-2025
yahoo.com
Institutions own 32% of Surrozen, Inc. (NASDAQ:SRZN) shares but private equity firms control 32% of the company
30-08-2025
yahoo.com
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
08-08-2025
yahoo.com
We Think Surrozen (NASDAQ:SRZN) Can Afford To Drive Business Growth
01-07-2025
yahoo.com
What is the current price of SURROZEN INC-CW25 (SRZNW:NASDAQ)?
The current price of SURROZEN INC-CW25 (SRZNW:NASDAQ) is $0.0191.
SURROZEN INC-CW25 (SRZNW:NASDAQ) absolute price change since previous trading day?
The absolute price change of SURROZEN INC-CW25 (SRZNW:NASDAQ) since the previous trading day is $0.
SURROZEN INC-CW25 (SRZNW:NASDAQ) percentage price change since previous trading day?
The percentage price change of SURROZEN INC-CW25 (SRZNW:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for SURROZEN INC-CW25 (SRZNW:NASDAQ)?
The most recent average sentiment score for SURROZEN INC-CW25 (SRZNW:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for SURROZEN INC-CW25 (SRZNW:NASDAQ)?
The most recent sentiment for SURROZEN INC-CW25 (SRZNW:NASDAQ) is .
SEC-8K** Filing Available For SURROZEN INC-CW25 (SRZNW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.